67th Annual Meeting of the Society of Thrombosis and Hemostasis Research
Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Follow-up evaluation of real-life-data documented by smart medication eDiary
W. Mondorf, H. Eichler, R. Fischer, K. Holstein, R. Klamroth, H. Richter, U. Sachs, C. Escuriola-Ettingshausen
Publiziertes Abstract: Hämostaseologie 2023; 43(S1) – DOI 10.1055/s-0042-1760534, öffnet in neuem Tab
Changes in hemophilia A therapy – an analysis of real-world data from smart medication eDiary over the past 10 years
A. Rösch, D. Schmoldt, W. Mondorf
Publiziertes Abstract: Hämostaseologie 2023; 43(S1): S57–S58 – DOI 10.1055/s-0042-1760548, öffnet in neuem Tab
At the forefront of the introduction of gene therapy in hemophilia A and B: Design and implementation of an innovative software platform („smart medication Gene“) for gene therapy
A. Rösch, D. Schmoldt, L. De Witte
Publiziertes Abstract: Hämostaseologie 2023; 43(S1): S69 – DOI 10.1055/s-0042-1760568, öffnet in neuem Tab